Matti Aapro, MD
Matti Aapro, MD, has been selected as the recipient of the Multinational Association of Supportive Care in Cancer’s (MASCC) 2016 Distinguished Service Award. The Award recognizes meritorious achievement and outstanding contributions to the Society and its mission. Candidates are nominated by their peers.
Currently Dean of the Multidisciplinary Oncology Institute in Genolier, Switzerland, Dr. Aapro is widely recognized for his achievements in numerous areas of oncology and supportive cancer care. His expertise and energetic leadership have significantly furthered the aims of MASCC around the world.
Service to MASCC
Dr. Aapro served as President of MASCC from 2004 to 2006 and has served several terms on MASCC’s Board of Directors, including the past three consecutive 2-year terms, from 2010 to 2016. He also served as Chair of MASCC’s 2005 Annual Meeting in Geneva. Dr. Aapro has also been active in and supportive of MASCC Study Groups. He is currently Chair of the Antiemetics Study Group and led the Study Group’s recent initiative to revise the MASCC Antiemetic Guidelines. In addition to his expertise in antiemetics, Dr. Aapro has broad knowledge in other areas of supportive care, such as anemia, neutropenia, osteoporosis, and geriatrics, and has been involved in developing guidelines on several topics. He has been instrumental in the organization of several MASCC Study Groups, with major input in the Antiemetics, Geriatrics, and Nutrition and Cachexia Groups.
Other Professional Activities
A past Board member of the European Society of Medical Oncology (ESMO) and a past member of the Board of the European Organization for Research and Treatment of Cancer, Dr. Aapro is now an Executive Board member of the International Society for Geriatric Oncology and a member of the Board of ECCO (European Cancer Organisation). He also is on the Board and coordinates the Sharing Progress in Cancer Care Program of the European School of Oncology. As a member of the Supportive Care Faculty of ESMO, he will lead the Supportive and Palliative Care track of the forthcoming ESMO 2017 Annual Meeting.
Dr. Aapro is Editor-in-Chief of Critical Reviews in Oncology/Hematology; Editor-in-Chief of the Quality of Life in Oncology Resource Centre; past Associate Editor of Annals of Oncology and of the European Journal of Cancer; and Associate Editor for the Geriatric Section of The Oncologist. He is a Founding Editor of the Journal of Geriatric Oncology; an Editorial Board member of Annals of Oncology, Current Opinions in Oncology, Journal of Supportive Care in Cancer, Oncologie, and Oncology; and a past Editorial Board member of the Journal of Clinical Oncology (breast section).
In addition to supportive care, Dr. Aapro’s main research interests include new drug development, breast cancer, and geriatric oncology. He is Doctor Honoris Causa of the University of Tampere (2013) and received the 2010 Acta Oncologica Award and the 2012 ASCO B.J. Kennedy Award.
Dr. Aapro received his medical degree from the Faculty of Medicine, University of Geneva, Switzerland, and was a fellow at the Arizona Cancer Center. He is the founding Chair of the Medical and Radiation Therapy Department at the European Institute of Oncology in Milan. ■
